Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Analyzing The FDA's Approach To Diversity In Clinical Trials
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
Reducing The Burden Of Patient Retention And Improving Continuity
Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
The Phase 2 Endpoint Dilemma
Phase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.
Advanced Strategies For Faster, More Effective Recruitment
Modern patient-first enrollment strategies are combining digital outreach with data-driven targeting and protocol-specific screeners to identify eligible patients while reducing site burden.

Keeping Your Trials In Motion And Use AI Where It Makes Sense
2/2/2026

Explore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.
Advancing Clinical Research In 2025: Meeting FDA Standards In DCT
1/22/2025

Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.
Advancing Alzheimer's Disease Therapies
9/3/2025

By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.
Where Study Simulation Fits In Clinical Trials
4/21/2026

Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data
2/25/2025

Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

RTSM Solutions That Adapt To Your Needs

At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
Top Patient Recruitment Solutions

AutoCruitment's patient recruitment services have assisted with 700+ trials in more than 38 countries. Looking for patients with over 120 different conditions, they have enrolled 14600+ patients and achieved a 97% increase in randomization.
Going The Extra Mile To Enhance Every Patient's Experience

Delve into the details of our Patient Navigator services, which are designed to eliminate patients’ barriers to clinical trial participation and maximize study outcomes through patient experience.
Bringing Endocrine And Metabolic Disease Treatments To Market

Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.